Oracle's CancerMPact Treatment Architecture Trends is a cloud-based utility that is intended to assist pharmaceutical companies in the analysis of historical and global cancer treatment patterns. With this new service, users can evaluate the influence of market events, including the approval of new drugs and the adoption of specific drug classes and drugs. The instrument is of particular value for the identification of commercial opportunities, strategic planning, and market evaluation in the United States, Europe, Japan, and China. For up to 31 tumor types in G8 markets, the service assesses current and historical trends in clinical management across all cancer treatment modalities, including surgical, radiologic, and systemic treatments, as well as untreated patient populations. The interactive interface will enable users to filter drug information by technology, target, and regimen, with the addition of new data in future updates.
Underlying the service is Oracle's proprietary market research, which collects direct responses from more than 7,500 oncology healthcare providers worldwide. These observations pertain to over 450,000 cancer patients who undergo treatment on a monthly basis. This solution offers pharmaceutical companies a comprehensive understanding of global cancer treatment trends and physician practices, thereby enabling them to make informed decisions in a swiftly evolving market. In the years ahead, Oracle intends to further enhance the capabilities of this service by incorporating supplementary data.
